Puma Biotechnology | PBYI - Capitalización De Mercado

Precio De Mercado
7.78
Cambio Diario
-0.02 -0.26%
Mensual
29.67%
Anual
175.89%
Q2 Expectativa
7.57




Capitalización De Mercado Cambio Fecha
Agios Pharmaceuticals USD 1.59B 745M 2025-12
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Amgen USD 176.25B 24.32B 2025-12
Biogen USD 25.82B 5.28B 2025-12
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Daiichi Sankyo JPY 6.34T 62.51B 2025-12
Esperion Therapeutics USD 885M 351M 2025-12
Exelixis USD 11.75B 959M 2025-12
Gilead Sciences USD 152.28B 14.55B 2025-12
Glaxosmithkline GBP 99.93B 13.05B 2025-12
Incyte USD 19.39B 2.83B 2025-12
MacroGenics USD 102M 4M 2025-12
Novartis USD 292.21B 26.55B 2025-12
Pfizer USD 141.57B 6.48B 2025-12
PTC Therapeutics USD 6.1B 1.22B 2025-12
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Takeda JPY 7.64T 774.9B 2025-12
TG Therapeutics USD 4.73B 1B 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
Vanda Pharmaceuticals USD 279M 6M 2024-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12